Cetera Investment Advisers
EDIT icon

Cetera Investment Advisers’s Editas Medicine EDIT Stock Holding History

Cetera Investment Advisers’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.3K Buy
16,153
+479
+3% +$1.4K ﹤0.01% 4766
2026
Q1 		$38.7K Sell
15,674
-414
-3% -$876 ﹤0.01% 4610
2025
Q4 		$33K Hold
16,088
– – ﹤0.01% 4548
2025
Q3 		$55.8K Buy
+16,088
New +$44.9K ﹤0.01% 4417
2021
Q4 		– Sell
-7,185
Closed -$295K – 1879
2021
Q3 		$295K Buy
7,185
+1,226
+21% +$67.2K ﹤0.01% 1450
2021
Q2 		$338K Buy
5,959
+1,183
+25% +$43.7K 0.01% 1342
2021
Q1 		$201K Sell
4,776
-1,577
-25% -$89.8K ﹤0.01% 1484
2020
Q4 		$445K Buy
+6,353
New +$261K 0.01% 1014

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Cetera Investment Advisers's EDIT Position: Q2 2026 in Review

Cetera Investment Advisers increased its Editas Medicine (EDIT) stake by 3.1% in Q2 2026, buying an estimated $1.4K and bringing the position to 16,153 shares worth $52.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4766.

Cetera Investment Advisers first reported a position in EDIT in Q4 2020 and has held it in 8 quarters since. The position peaked at $445K in Q4 2020. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Cetera Investment Advisers held 16,153 shares of Editas Medicine worth $52.3K as of Q2 2026.
  • Cetera Investment Advisers bought 479 Editas Medicine shares in Q2 2026, an estimated $1.4K.
  • Editas Medicine made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4766 holding.
  • Cetera Investment Advisers first reported a position in Editas Medicine in Q4 2020 and has held it in 8 quarters since.
  • Cetera Investment Advisers's Editas Medicine position peaked at $445K in Q4 2020.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.